title: Stent failure due to simultaneous aggressive neoatherosclerosis of first- and current-generation drug-eluting stents.
authors.affiliation: Interventional Cardiology Division, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
authors.forename: Kenichi
authors.initials: K
authors.lastname: Komukai
authors.forename: Chiara
authors.initials: C
authors.lastname: Bernelli
authors.forename: Vasile
authors.initials: V
authors.lastname: Sirbu
authors.forename: Giulio
authors.initials: G
authors.lastname: Guagliumi
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000628:therapy*; D023903:Coronary Restenosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D003328:Coronary Thrombosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D003331:Coronary Vessels / Q000000981:diagnostic imaging / Q000473:pathology*; D054855:Drug-Eluting Stents; D000068338:Everolimus / Q000008:administration & dosage; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects* / Q000295:instrumentation*; D058226:Plaque, Atherosclerotic; D011474:Prosthesis Design; D011475:Prosthesis Failure; D019233:Retreatment; D017131:Thrombectomy; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents; D000068338:Everolimus; D017239:Paclitaxel